Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
5(22%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
2
9%
Ph phase_2
3
13%
Ph phase_1
2
9%
Ph not_applicable
7
30%
Ph phase_3
3
13%
Ph phase_4
6
26%

Phase Distribution

4

Early Stage

3

Mid Stage

9

Late Stage

Phase Distribution23 total trials
Early Phase 1First-in-human
2(8.7%)
Phase 1Safety & dosage
2(8.7%)
Phase 2Efficacy & side effects
3(13.0%)
Phase 3Large-scale testing
3(13.0%)
Phase 4Post-market surveillance
6(26.1%)
N/ANon-phased studies
7(30.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

11 of 11 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

23

all time

Status Distribution
Active(5)
Completed(11)
Other(7)

Detailed Status

Completed11
unknown7
Recruiting4
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
23
Active
5
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (8.7%)
Phase 12 (8.7%)
Phase 23 (13.0%)
Phase 33 (13.0%)
Phase 46 (26.1%)
N/A7 (30.4%)

Trials by Status

unknown730%
completed1148%
recruiting417%
active_not_recruiting14%

Recent Activity

Clinical Trials (23)

Showing 20 of 23 trialsScroll for more
NCT07434206Phase 2

Safety and Efficacy of Dexmedetomidine in Controlling Hemodynamics During Resection of Active Thyroid Secreting Tumors

Active Not Recruiting
NCT03063073Phase 3

Efficacy and Safety of Dexmedetomidine Added to Modified Pectoral's Block

Completed
NCT05788393Phase 4

Opioid Sparing Analgesia Continuous Intraoperative Infusion of Dexmedetomidine Versus Lidocaine for Laparoscopic Cholecystectomy

Completed
NCT06867302Not Applicable

Dexmedetomidine and Agitation After Nasal Surgery

Recruiting
NCT06386770Phase 3

Systemic Versus Local Dexmedetomidine as An Adjuvant to Bupivacaine in Ultrasound Guided Erector Spinae Block

Recruiting
NCT06386783Phase 3

Fentanyl Versus Dexmedetomidine as an Adjuvant to Bupivacaine in Spinal Anesthesia ; Peritoneal Symptomatic Effects

Recruiting
NCT06614881Not Applicable

Dexmedetomidine Dosage for Postoperative Delirium and Cognitive Function in Elderly TKA Patients

Completed
NCT06318546Phase 1

Dexmedetomidine in Spinal Anesthesia Decreasing Post Spinal Shivering in Caesarean Section

Completed
NCT06090955Not Applicable

Modulating Surgery-Induced Blood-Brain Barrier Disruption in Elderly

Recruiting
NCT06103721Phase 4

Role of Nebulized Dexmedetomidine in Blunting the Effects of Direct Laryngoscopy and Endotracheal Tube on Heart Rate and Blood Pressure.

Unknown
NCT05004519Not Applicable

Benefits of Opioid Free Anesthesia on Morphine Consumption in Gastric Bypass

Completed
NCT05892705Phase 4

Intrathecal Dexmedetomidine to Decrease Postoperative Nausea and Vomiting and Shivering.

Completed
NCT05840328Phase 4

DEXMEDETOMIDINE in NORMAL VAGINAL DELIVERY

Unknown
NCT05689242Phase 4

Intravenous Nalbuphine Versus Intravenous Dexmedetomidine for Conscious Sedation in Patients Undergoing Colonoscopy

Unknown
NCT05225610Not Applicable

Valsalva Manoeuvre and Intravenous Dexmedetomidine on Attenuating Pain During Propofol Injection in Upper GIT Endoscopy

Completed
NCT03989609Phase 2

Dexmedetomidine in Modifying Immune Paralysis In Patient With Septic Shock

Completed
NCT04730375Phase 2

Evaluation of the Effect of Different Doses Dexmedetomidine Infusion on Lung Mechanics and Oxygenation in Obese Patients

Completed
NCT04285255Not Applicable

Quality of Recovery Following Opioids Free Anaesthesia in Laparoscopic Sleeve Gastrectomy

Completed
NCT03778671Phase 1

Dexmedetomidine Versus Fentanyl Added to Levobupivacaine for Transversus Abdominis Plane (TAP) Block

Completed
NCT04659642Early Phase 1

Attenuation of Airway and Cardiovascular Responses to Extubation in Chronic Smokers

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
23